NIH to evaluate remdesivir treatment for COVID during pregnancy

WASHINGTON (NEWS10) — The National Institutes of Health (NIH) is funding a study into the effects of prescription remdesivir on those who are both pregnant and COVID-positive. Called “IMPAACT 2032,” the study, conducted at 17 sites in the U.S., will examine how pregnant people metabolize and digest the drug, and whether it poses side effects. […]

Clinical outcomes of hospitalized COVID-19 patients treated with

Messages from the COVID-19 Response Task Force

Remdesivir for the treatment of hospitalized patients with severe

Therapeutic dilemmas in addressing SARS-CoV-2 infection

13 Things To Know About Paxlovid, the Latest COVID-19 Pill > News

Effect of remdesivir post hospitalization for COVID-19 infection

Science Is Answering Questions About COVID-19 and Pregnancy

Covid-19 Research Opens to Little-Studied Group: Pregnant Patients

Frontiers Drugs for the prevention and treatment of COVID-19 and

Evaluation & Management of COVID-19 in Pregnancy

Cureus Compassionate Use of Remdesivir in Pregnancy: A Case